RT Journal Article
T1 ASO Author Reflection: The End of the Tower of Babel in Pseudomyxoma Peritonei.
A1 Arjona-Sanchez, Alvaro
A1 Valenzuela-Molina, Francisca
A1 Rufian-Andujar, Blanca
A1 Romero-Ruiz, Antonio
K1 Hyperthermic intraperitoneal chemotherapy
K1 Cytoreduction surgical procedures
K1 Rare diseases
K1 World health organization
AB Peritoneal pseudomyxoma (PMP) is a rare disease that is treated in referral centres via cytoreductive surgery in association with hyperthermic Intraperitoneal chemotherapy (HIPEC). Given its particular biological andhistological characteristics, the nomenclature used to describe PMP has not yet been standardized and therefore several histological classifications are available, including those by Ronnett et al. in 1995,1 Bradley et al. in 2006,2 the WHO classification published in 2010,3 and the American Joint Committee on Cancer (AJCC) 8th edition in 2017.4 This Tower of Babel in PMP has made it very difficult to compare and share the data between different centres.
YR 2021
FD 2021-01-05
LK http://hdl.handle.net/10668/17023
UL http://hdl.handle.net/10668/17023
LA en
NO Arjona-Sanchez Á, Valenzuela-Molina F, Rufian-Andujar B, Romero-Ruiz A. ASO Author Reflection: The End of the Tower of Babel in Pseudomyxoma Peritonei. Ann Surg Oncol. 2021 May;28(5):2828
DS RISalud
RD Apr 17, 2025